Jiangsu Recbio Technology (02179) Announces January 2026 Monthly Return on Movements in Securities

Bulletin Express02-02

Jiangsu Recbio Technology Co., Ltd. (02179) reported that, as of January 31, 2026, the total authorized share capital remained at RMB 626,075,702. This comprises 297,937,013 Domestic Shares, 12,000,000 Unlisted Foreign Shares, and 316,138,689 H Shares, each with a par value of RMB 1.

In terms of issued shares, there were no changes during the month. Issued Domestic Shares remained at 297,937,013, Unlisted Foreign Shares at 12,000,000, and H Shares at 316,138,689. No treasury shares were recorded.

The company confirmed that its public float is in compliance with the applicable requirements under the listing rules. There were no share options, warrants, convertibles, or other arrangements leading to changes in the company’s share capital during the reporting period.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment